Navigation Links
Commercial Medical and Pharmacy Benefit Enrollment Down in New York
Date:6/17/2009

HealthLeaders-InterStudy's Managed Market Surveyor-Rx Evaluates How Medical and Pharmacy Lives are Covered at National, State and MSA Levels

NASHVILLE, Tenn., June 17 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that medical and pharmacy benefit enrollment in New York state declined between July 2008 and January 2009. According to data available in the newest release of Managed Market Surveyor-Rx, medical benefit enrollment declined 2.7 percent throughout the state (approximately 340,000 lives), while pharmacy benefit enrollment declined 3.6 percent (approximately 335,000 lives).

"The economy plays a large role in the enrollment declines seen in New York, particularly as the number of unemployed in the state nearly doubled in 2008," said Rebecca Waller, senior health plan analyst with HealthLeaders-InterStudy. "Overall, enrollment has decreased in New York at a higher rate than most other states."

In some states, insurers are able to retain some business lost through layoffs and business closures with sales to the individual market, but that sector is less of a factor in New York. State rules regarding medical underwriting make prices for individual designs relatively high.

The shifts seen in the New York market are just one example of the data available in Managed Market Surveyor-Rx.

"Managed Market Surveyor-Rx allows users to identify managed care enrollment trends across plans, plan type and geography to better inform resource deployment," said Russell Workman, principal director of data operations for HealthLeaders-InterStudy. "For pharmaceutical companies contracting with plans operating in New York, and throughout the country, our database provides a comprehensive assessment of a plan's market share by metropolitan statistical area (MSA) and its capacity in that market."

Why Pharmaceutical Companies Need Managed Market Surveyor-Rx

Managed Market Surveyor-Rx delivers medical and pharmacy benefit enrollment data by managed care organization and geography (national, state, MSA) to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy's proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. Study Shows Increases in Working After 65 and Using Commercial Insurance
3. Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment
4. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
5. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
6. ProSolv Version 4.0.2 Makes Commercial Debut at ASE
7. moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
8. Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
9. BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
10. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
11. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology: